Antitumor Activity of Amivantamab (JNJ-61186372), an...

  • Main
  • 2020 / 05
  • Antitumor Activity of Amivantamab (JNJ-61186372), an...
Cancer Discovery 2020 / 05

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC

Yun, Jiyeon, Lee, Soo-Hwan, Kim, Seok-Young, Jeong, Seo-Yoon, Kim, Jae-Hwan, Pyo, Kyoung-Ho, Park, Chae-Won, Heo, Seong Gu, Yun, Mi Ran, Lim, Sangbin, Lim, Sun Min, Hong, Min Hee, Kim, Hye Ryun, Thayu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-20-0116
Date:
May, 2020
File:
PDF, 7.65 MB
2020
Conversion to is in progress
Conversion to is failed